Everstone Group buys stake in OmniActive

Private equity and real estate investment firm The Everstone Group has invested $35m in OmniActive Health Technologies (OmniActive) to further accelerate its growth in the fast-expanding nutraceuticals sector.

It is the third investment by Everstone in the healthcare and wellness sector in less than a year.

India-based OmniActive supplies naturally sourced ingredients for eye health, weight management and heart health to global nutraceutical companies.

It owns manufacturing facilities, as well as research and development centres across India and Canada, and has sales and marketing presence across the US, Europe and Asia.

OmniActive managing director Sanjaya Mariwala said: “We welcome this partnership with the Everstone Group.

“With the support of its experienced teams and funding, OmniActive looks forward to building on our history of solid organic growth by further strengthening our presence globally using innovative products and technologies.

“This will be done by also growing inorganically to bring a wider product portfolio of responsibly made ingredients to our customers through our strategic acquisitions."

The investment from Everstone will help OmniActive in diversifying and expanding its offerings, as well as use this investment towards its inorganic growth strategy and acquisition opportunities.

Everstone Group co-founder and managing partner Sameer Sain said: “This investment aims at helping OmniActive scale its already strong presence in the fast-growing nutraceutical space."